Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuchen Cao
Observed names:
Xu-Chen Cao,
Xu-chen Cao
Institution:
Tianjin Medical University Cancer Institute and Hospital
Observed institutions:
Ministry of Education of the People's Republic of China,
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0000-0001-8829-4530
Observed ORCID:
0000-0001-8829-4530
OpenAlex ID:
A5103206273
Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells.
2013
·
Xuchen Cao
, Bowen Liu
, et al.
·
Chinese Journal of Cancer Research
·
147
MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG
2022
·
Li-Ming Xu
, Jiao Zhang
, et al.
·
Oncogene
·
32
Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN
2020
·
Li-Ming Xu
, Hao Yu
, et al.
·
Frontiers in Cell and Developmental Biology
·
28
PDF
Upconverting and persistent luminescent nanocarriers for accurately imaging-guided photothermal therapy
2017
·
Peiqi Zhao
, Wei Ji
, et al.
·
Materials Science and Engineering C
·
28
RETRACTED ARTICLE: Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2
2021
·
Yue Zhang
, Yaoyi Wang
, et al.
·
Bioengineered
·
20
miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin
2020
·
Faping You
, Junhui Li
, et al.
·
Cancer Management and Research
·
15
PDF
Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis
2024
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
Frontiers in Oncology
·
12
PDF
Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trial
2025
·
Wen-Jia Zuo
, Lin-xiao-xi Ma
, et al.
·
Cancer Letters
·
4
The role of surgery on locoregional treatment of patients with breast cancer newly diagnosed with ipsilateral supraclavicular lymph node metastasis
2022
·
Bo-Wen Liu
, Li-Xuan Chen
, et al.
·
Journal of Cancer Research and Therapeutics
·
4
Addendum: Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women
2020
·
Yujuan Xiang
, Wenzhong Zhou
, et al.
·
Frontiers in Endocrinology
·
1
PDF
Abstract P5-07-23: Efficacy and Safety of Pyrotinib Combined with Trastuzumab and Aromatase Inhibitor in Neoadjuvant Treatment of HER2+/HR+ Breast Cancer: A Single-Arm, Multi-Center Phase II Exploratory Study
2025
·
Jie Ge
, XiangChao Meng
, et al.
·
Clinical Cancer Research
Abstract PO1-27-01: Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 Trial
2024
·
Qingyuan Zhang
, Shusen Wang
, et al.
·
Cancer Research
The combination of VX-680 and ABT-737 efficiently promotes breast cancer cell line apoptosis
2012
·
Yue Zhang
, Bin Zhang
, et al.
·
Zhonghua shiyan waike zazhi
Show more works
View as search
Works count:
13
Citation count:
291
H-index:
7
I10-index:
7
Year
Topic
Type